IDM Pharma (IDMI) Reports Q4 Loss of $0.07
IDM Pharma, Inc. (Nasdaq: IDMI) reports Q4 loss of $0.07, compared to a net loss of $0.11 in the same quarter last year. Revenue for the quarter was $300K, versus $5.6 million in Q407.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
